AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Griknil-MV 2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Aplonis Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Griknil-MV 2 Tablet SR

Diabex Duo 2mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo 2mg with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and treat hypoglycemia; maintain regular meals and carry a rapid-acting glucose source like candy or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Diabex Duo 2mg is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Griknil-MV 2 Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Griknil-MV 2 Tablet SR

Managing type 2 diabetes

Major Benefits of Griknil-MV 2 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Griknil-MV 2 Tablet SR on an empty stomach.

Common Side effects of Griknil-MV 2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Griknil-MV 2 Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Griknil-MV 2 Tablet SR should be consumed on an empty stomach.

How Griknil-MV 2 Tablet SR works:

Griknil-MV 2 sustained-release tablets contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Griknil-MV 2 Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Griknil-MV 2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against the risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Griknil-MV 2 Tablet may pose a risk during lactation. Available evidence from humans indicates potential transfer to breast milk, with the possibility of infant harm.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Griknil-MV 2 Tablet SR is contraindicated in patients with renal impairment and should be omitted. Physician consultation is advised. Furthermore, its use is discouraged in individuals with advanced kidney disease.

LiverLiverCAUTION

Exercise caution when administering Griknil-MV 2 Tablet SR to individuals with hepatic impairment. Dosage modification of Griknil-MV 2 Tablet SR may be necessary. Physician consultation is advised. A reduced initial dose of Griknil-MV 2 Tablet SR is typically prescribed for patients exhibiting mild to moderate liver dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Griknil-MV 2 Tablet SR :

Should you forget a Griknil-MV 2 Tablet SR dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Griknil-MV 2 Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Griknil-MV 2 Tablet SR

Griknil-MV 2 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus. This formulation helps regulate blood sugar in adults when used with a healthy diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar increases. This combination therapy is unsuitable for type 1 diabetes.
Griknil-MV 2 Tablet SR administration may result in common adverse reactions including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, skin eruptions, and respiratory infections.
Patients with hypersensitivity to Griknil-MV 2 Tablet SR constituents or inactive ingredients should not use this medication. Its administration is contraindicated in individuals with moderate-to-severe renal impairment, inflammatory bowel disorders, colonic ulcers, and metabolic acidosis, such as diabetic ketoacidosis.
Combining Griknil-MV 2 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar and heighten the risk of lactic acidosis.
Griknil-MV 2 Tablet SR can indeed lower blood sugar, resulting in hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any remaining medication. Prevent access by children, pets, and others.
Griknil-MV 2 Tablet SR
103
MRP 125
17% off